Administration Rates of the Tdap Vaccine in Obstetric Patients.

Jamie KoernerAlicia B ForinashAbigail M YanceyJessica BrinkmeyerSpencer DingmanCollin MillerJudy ThompsonLaura BerginJulia D LópezAmy Ravin

Published in: The Annals of pharmacotherapy (2018)

The Tdap vaccine rate was 65.8%, with 59.9% of patients receiving the vaccine within the recommended ACIP timeframe. Further education, improvements in documentation, and chart reminders are needed to enhance administration.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
healthcare
pregnant women
peritoneal dialysis
prognostic factors
patient reported